Azithromycin






452 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
51 15361366 Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection. Am J Respir Crit Care Med 2004 Dec 15 3
52 15524029 [Evaluation of clinical effectiveness and direct costs of azithromycin treatment for exacerbation of chronic obstructive pulmonary disease in hospitalized patients and ambulatory care]. Pol Merkur Lekarski 2004 May 1
53 15566918 Effect of azithromycin therapy on coronary circulation in patients with coronary artery disease. Am J Cardiol 2004 Dec 1 1
54 15610401 Clinical and immunological effects of azithromycin in Behçet's disease. J Oral Pathol Med 2005 Jan 1
55 15885263 Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. Toxicol Appl Pharmacol 2005 May 15 2
56 16085674 Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2006 Jan 4
57 16096858 Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin. Clin Exp Med 2005 Jul 3
58 16113783 Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells. Thromb Haemost 2005 Jul 2
59 16167518 Long-term azithromycin in cystic fibrosis: another possible mechanism of action? J Chemother 2005 Aug 2
60 16185859 Exploring the mechanisms of macrolides in cystic fibrosis. Respir Med 2006 Apr 2
61 16395097 Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city. Pediatr Infect Dis J 2006 Jan 2
62 16400877 Incidence of Staphylococcus aureus isolated from patients treated at the Clinical Center of Skopje, Macedonia, with special attention to MRSA. Acta Microbiol Immunol Hung 2005 1
63 16416302 Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate. Eur J Clin Pharmacol 2006 Mar 1
64 16464259 The GCC repeat length in the 5'UTR of MRP1 gene is polymorphic: a functional characterization of its relevance for cystic fibrosis. BMC Med Genet 2006 Feb 7 1
65 16641453 Novel effects of azithromycin on tight junction proteins in human airway epithelia. Antimicrob Agents Chemother 2006 May 3
66 16698012 Anti-inflammatory activity of azithromycin attenuates the effects of lipopolysaccharide administration in mice. Eur J Pharmacol 2006 Jun 6 2
67 16741151 Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2006 Sep 1 3
68 17012372 Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-kappaB activation in a cystic fibrosis epithelial cell line. Am J Physiol Lung Cell Mol Physiol 2007 Jan 2
69 17045242 Anti-inflammatory effects of azithromycin in cystic fibrosis airway epithelial cells. Biochem Biophys Res Commun 2006 Dec 1 2
70 17061983 Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007 Jan 3
71 17064416 Azithromycin reduces spontaneous and induced inflammation in DeltaF508 cystic fibrosis mice. Respir Res 2006 Oct 25 2
72 17083011 Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 2006 Dec 1 1
73 17088870 No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block. Br J Pharmacol 2006 Dec 1
74 17110371 In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J Biol Chem 2007 Jan 26 2
75 17207028 Efficacy of azithromycin administration in prevention of respiratory tract infection after bronchoscopic biopsy: a randomized, controlled trial. Respirology 2007 Jan 1
76 17210769 Azithromycin selectively reduces tumor necrosis factor alpha levels in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother 2007 Mar 4
77 17296622 The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos 2007 May 2
78 17302905 Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol 2007 Mar 5
79 17306081 [Protection of azithromycin against pulmonary II epithelial cell injuries induced by cigarette smoke extract and relevant mechanisms]. Zhongguo Dang Dai Er Ke Za Zhi 2007 Feb 1
80 17667842 Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants. Pediatr Res 2007 Oct 10
81 17963679 Azithromycin protects against hyperoxic lung injury in neonatal rats. J Investig Med 2007 Sep 2
82 17994436 Azithromycin prevents recurrence of severe trichiasis following trichiasis surgery: STAR trial. Ophthalmic Epidemiol 2007 Sep-Oct 1
83 18027988 Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Clin Pharmacokinet 2007 1
84 18053438 Azithromycin for PID beats doxycycline on all counts. J Fam Pract 2007 Dec 1
85 18226504 Pharmacodynamics of doxycycline for chemoprophylaxis of Lyme disease: preliminary findings and possible implications for other antimicrobials. Int J Antimicrob Agents 2008 Mar 1
86 18230544 Effects of azithromycin on the expression of ATP binding cassette transporters in epithelial cells from the airways of cystic fibrosis patients. J Chemother 2007 Dec 12
87 18230686 Azithromycin alters macrophage phenotype. J Antimicrob Chemother 2008 Mar 4
88 18420960 Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 Jul 15 4
89 18435685 Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury. Transpl Int 2008 Jul 1
90 18487355 Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. Am J Physiol Lung Cell Mol Physiol 2008 Jul 1
91 18503189 CRP regulator modulates multidrug resistance of Escherichia coli by repressing the mdtEF multidrug efflux genes. J Antibiot (Tokyo) 2008 Mar 1
92 18758509 Lysosomotropic drugs inhibit maturation of transforming growth factor-beta. Can J Physiol Pharmacol 2008 Sep 1
93 18761689 Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008 Oct 2
94 18853090 Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting. Clin Res Cardiol 2009 Jan 1
95 18931390 Different effects of telithromycin on MUC5AC production induced by human neutrophil peptide-1 or lipopolysaccharide in NCI-H292 cells compared with azithromycin and clarithromycin. J Antimicrob Chemother 2009 Jan 3
96 18946018 Mechanism of azithromycin treatment on gingival overgrowth. J Dent Res 2008 Nov 4
97 18971093 Azithromycin attenuates effects of lipopolysaccharide on lung allograft bronchial epithelial cells. J Heart Lung Transplant 2008 Nov 2
98 19052724 Effects of macrolides on proinflammatory epitopes on endothelial cells in vitro. Arch Toxicol 2009 May 4
99 19097986 Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells. Am J Respir Cell Mol Biol 2009 Aug 5
100 19131424 Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli. J Antimicrob Chemother 2009 Mar 1